Citation

Alconero Camarero AR, Sangrador Rasero A, Casaus Pérez M, Mirones Valdeolivas LE, Muñoz Cacho P. Rev. Enferm. 2006; 29(12): 6-10.

Vernacular Title

Farmacos cardiovasculares. Riesgo para la conduccion de vehiculos.

Affiliation

EUE Casade Salud Valdecilla, Universidad de Cantabria. alconear@unican.es

Copyright

(Copyright © 2006, Ediciones ROL)

DOI

unavailable

PMID

17260571

Abstract

OBJECTIVE: To categorize cardiovascular pharmaceuticals according to their respective effect on one's capacity to drive a vehicle. Methodology: an analysis of the technical file for 299 pharmaceutical products belonging to 1 lsubgroups inside the main category of therapeutic products related to the cardiovascular apparatus. Information compiled includes: the existence, or lack of, a section which warns of the possible effects of the medication on a person's capacity to drive a vehicle; in those affirmative cases, a statement specifying those effects. CONCLUSIONS: 32.1% of pharmaceutical products do not comply with the existing legislation and approximately half of those pharmaceutical products do not have a section on their effects on a person's capacity to drive a vehicle, or they state these products have an effect but do not bear an influence even though they can provoke important effects.

Language: es